Cargando…

Artemisinin resistance and malaria elimination: Where are we now?

The emergence of artemisinin resistance is a major obstacle to the global malaria eradication/elimination programs. Artemisinin is a very fast-acting antimalarial drug and is the most important drug in the treatment of severe and uncomplicated malaria. For the treatment of acute uncomplicated falcip...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanboonkunupakarn, Borimas, Tarning, Joel, Pukrittayakamee, Sasithon, Chotivanich, Kesinee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538393/ https://www.ncbi.nlm.nih.gov/pubmed/36210819 http://dx.doi.org/10.3389/fphar.2022.876282

Ejemplares similares

Sequential Open-Label Study of the Safety, Tolerability, and Pharmacokinetic Interactions between Dihydroartemisinin-Piperaquine and Mefloquine in Healthy Thai Adults
por: Hanboonkunupakarn, Borimas, et al.
Publicado: (2019)

K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar
por: Win, Aye A., et al.
Publicado: (2016)

Erratum to: K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar
por: Win, Aye A., et al.
Publicado: (2016)

Diagnosis of Murine Typhus by Serology in Peninsular Malaysia: A Case Report Where Rickettsial Illnesses, Leptospirosis and Dengue Co-Circulate
por: Yuhana, Yazli, et al.
Publicado: (2019)

The threat of artemisinin resistant malaria in Southeast Asia
por: Hanboonkunupakarn, Borimas, et al.
Publicado: (2016)

Laboratory Detection of Artemisinin-Resistant Plasmodium falciparum
por: Chotivanich, Kesinee, et al.
Publicado: (2014)

Rickettsial Infections Are Neglected Causes of Acute Febrile Illness in Teluk Intan, Peninsular Malaysia
por: Yuhana, Muhamad Yazli, et al.
Publicado: (2022)

Correction: Yuhana et al. Rickettsial Infections Are Neglected Causes of Acute Febrile Illness in Teluk Intan, Peninsular Malaysia. Trop. Med. Infect. Dis. 2022, 7, 77
por: Yuhana, Muhamad Yazli, et al.
Publicado: (2022)

Pharmacokinetic Interactions between Primaquine and Pyronaridine-Artesunate in Healthy Adult Thai Subjects
por: Jittamala, Podjanee, et al.
Publicado: (2014)

Epidemiology of Plasmodium vivax Malaria Infection in Nepal
por: Rijal, Komal Raj, et al.
Publicado: (2018)

Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers
por: von Seidlein, Lorenz, et al.
Publicado: (2019)

Village malaria worker performance key to the elimination of artemisinin-resistant malaria: a Western Cambodia health system assessment
por: Canavati, Sara E., et al.
Publicado: (2016)

Tuberculosis elimination: where are we now?
por: Matteelli, Alberto, et al.
Publicado: (2018)

Transmission of Artemisinin-Resistant Malaria Parasites to Mosquitoes under Antimalarial Drug Pressure
por: Witmer, Kathrin, et al.
Publicado: (2020)

Impact of glucose-6-phosphate dehydrogenase deficiency on dengue infection in Myanmar children
por: May, Win Lai, et al.
Publicado: (2019)

Editorial: Antipsychotics of New Generation: Where Are We now?
por: Lipina, Tatiana V., et al.
Publicado: (2021)

A Comparison of Two Short-Course Primaquine Regimens for the Treatment and Radical Cure of Plasmodium vivax Malaria in Thailand
por: Pukrittayakamee, Sasithon, et al.
Publicado: (2010)

Efficacy of Primaquine in Preventing Short- and Long-Latency Plasmodium vivax Relapses in Nepal
por: Rijal, Komal Raj, et al.
Publicado: (2019)

Enantiospecific pharmacokinetics and drug–drug interactions of primaquine and blood-stage antimalarial drugs
por: Chairat, Kalayanee, et al.
Publicado: (2018)

Maternal and Neonatal Tetanus Elimination: Where are We Now?
por: Dhir, Shashi Kant, et al.
Publicado: (2021)

Interleukin-1 Blockade in Polygenic Autoinflammatory Disorders: Where Are We now?
por: Malcova, Hana, et al.
Publicado: (2021)

Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin–piperaquine in healthy volunteers
por: Chotsiri, Palang, et al.
Publicado: (2017)

Acidosis and acute kidney injury in severe malaria
por: Sriboonvorakul, Natthida, et al.
Publicado: (2018)

Effect of High-Dose or Split-Dose Artesunate on Parasite Clearance in Artemisinin-Resistant Falciparum Malaria
por: Das, Debashish, et al.
Publicado: (2013)

Pharmacokinetic Interactions between Primaquine and Chloroquine
por: Pukrittayakamee, Sasithon, et al.
Publicado: (2014)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Where are we now?
Publicado: (1977)

A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria
por: Mbengue, Alassane, et al.
Publicado: (2015)

Open-Label Crossover Study of Primaquine and Dihydroartemisinin-Piperaquine Pharmacokinetics in Healthy Adult Thai Subjects
por: Hanboonkunupakarn, Borimas, et al.
Publicado: (2014)

Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response
por: Zhu, Lei, et al.
Publicado: (2022)

Activity of Ivermectin and Its Metabolites against Asexual Blood Stage Plasmodium falciparum and Its Interactions with Antimalarial Drugs
por: Yipsirimetee, Achaporn, et al.
Publicado: (2023)

Resistant Hypertension: Where are We Now and Where Do We Go from Here?
por: Pathan, Mansur K, et al.
Publicado: (2020)

NIPPV: Where Are We Now?
por: Fakharian, Atefeh, et al.
Publicado: (2013)

Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
por: Wasilewicz, Michał P., et al.
Publicado: (2023)

Pharmacokinetics of Orally Administered Oseltamivir in Healthy Obese and Nonobese Thai Subjects
por: Jittamala, Podjanee, et al.
Publicado: (2014)

The dynamic of asymptomatic Plasmodium falciparum infections following mass drug administrations with dihydroarteminisin–piperaquine plus a single low dose of primaquine in Savannakhet Province, Laos
por: Pongvongsa, Tiengkham, et al.
Publicado: (2018)

Advances and roadblocks in the treatment of malaria
por: Hanboonkunupakarn, Borimas, et al.
Publicado: (2020)

The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum
por: Chotivanich, Kesinee, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_mo1hrurid22eu5dtipq5bif68c